Drug Discovery World

FEBRUARY 12, 2024

The top ten selling medicines worldwide and multiple vaccines, including those for Covid-19, hepatitis B and whooping cough, target membrane proteins. Membrane proteins are crucial molecules on the surface of cells with numerous biological functions, such as sensing hormones or cell communication.

Research 105

Research Drugs Engineer Protein 105

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. It is a major backer of Kadans, one of the groups behind the recently-announced Canary Wharf life sciences hub in east London.

Life Science 57

Life Science Vaccination Vaccine Marketing 57

pharmaphorum

NOVEMBER 23, 2021

Sanofi is the first pharma company to partner with Baidu on its LinearDesign AI platform, which has been developed specifically to optimise the sequence of mRNA-based vaccines and drugs. billion earlier this year. Specific financial terms have not been disclosed. Specific financial terms have not been disclosed.

Licensing 104

Licensing Licensing Vaccination Vaccine 104

Drug Discovery World

SEPTEMBER 26, 2023

Although not a new area of science, the prominence of this technology and its applications – evident during the Covid-19 pandemic – have increased of late. Download this In Focus eReport to gain a full understanding of the current market for synthetic biology and its promise to treat disease in a new way.

Drugs 52

Drugs Marketing Gene Development 52

Drug Discovery World

OCTOBER 5, 2023

Join DDW’s Megan Thomas and Reece Armstrong with sponsors Taconic for the first DDW Turning Science into Business Summit, ‘ Cancer research opportunities and advances ’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. What are the best research tools to aid development of new treatments and vaccines?

Research 52

Research Antibody Medicine RNA 52

pharmaphorum

MARCH 4, 2021

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. A scheme providing £500 payments to people self-isolating has been extended in England until the summer.

Vaccination 104

Vaccination Vaccine Development Life Science 104

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Antibody 130

Antibody DNA Production Medicine 130

Pharmaceutical Technology

MAY 8, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

Pharma in Brief

JUNE 26, 2022

The CTF is part of Canada’s broader Biomanufacturing and Life Sciences Strategy , a $2.2 billion investment which aims to boost Canada’s biomanufacturing and life science sector and ensure Canada’s readiness for future pandemics and health emergencies. The Clinical Trials Fund.

Clinical Trials 52

Clinical Trials Clinical Trials Trial Funding Trials 52

Pfizer

SEPTEMBER 27, 2022

We need YOU to design for science! We need YOU to design for science! More of us than ever need science to restore not just the health of our loved ones, but life as we remember it. The  The power of science is the key to unlocking the answers to the world’s most challenging medical questions. Calling All Creatives!

Medicine 52

Medicine Vaccination Vaccine Licensing 52

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccination 93

Vaccination Vaccine Development Marketing 93

The Pharma Data

MAY 31, 2022

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda ( TSE:4502/NYSE:TAK ) announced to transfer the marketing authorization in Japan for Moderna’s COVID-19 vaccine Spikevax TM (mRNA-1273) from Takeda to Moderna in Japan as of August 1, 2022. Moderna, Inc., ” Authorized Use.

Vaccination 52

Vaccination Vaccine Marketing RNA 52

Pharmaceutical Technology

NOVEMBER 22, 2022

These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognised for generics production. The Chinese government announced its ten-year 'Made in China 2025' strategic plan in 2015, which aimed to make the country a global leader in several high-tech industries.

Manufacturing 162

Manufacturing Gene Therapy Gene Contract Manufacturing 162

Velocity Clinical Research

APRIL 5, 2024

Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinical trial science and deliver vital new drugs and treatments to patients quicker. When it comes to clinical trials, it’s an issue with deep roots, Lang notes.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Pharmaceutical Technology

MAY 24, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Protein 130

Protein Antibody Medicine Development 130

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

JANUARY 13, 2023

Sanofi Ventures invests in innovators working in areas including immunology and inflammation, rare diseases, oncology, cell and gene therapy, vaccines, and digital health and data science. The team partners across all stages of the private company lifecycle, from Seed to Series B and beyond.

Gene Therapy 52

Gene Therapy Business Development Gene Vaccination 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We We focus on our internal research and development efforts, but we always look for external opportunities.

FDA Approval 287

FDA Approval Clinical Trials Clinical Trials Development 287

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Antibody 130

Antibody DNA Genome Genomics 130

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. In the medtech space, neuromodulation was a big area.

Life Science 98

Life Science Vaccination Vaccine Trials 98

pharmaphorum

NOVEMBER 24, 2021

The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients. Getting the UK’s COVID vaccine and treatments programme ahead of schedule. Why is this important for the UK? Conclusion.

Life Science 97

Life Science Regulation Medicine Vaccination 97

pharmaphorum

JUNE 29, 2021

Sanofi has just significantly increased its investment in mRNA vaccine development, earmarking €400 million ($475 million) a year in R&D funding to an effort that it hopes will deliver at least six clinical-stage candidates by 2025. . Sanofi isn’t the only vaccine company that has made mRNA a key element of its R&D strategy.

Vaccination 52

Vaccination Vaccine Protein Clinical Trials 52

The Pharma Data

JULY 29, 2021

Takeda Will Focus its Efforts on Dengue, Zika and Pandemic Vaccines. HilleVax), a biopharmaceutical company to develop and commercialize Takeda’s norovirus vaccine candidate. President of the Global Vaccine Business Unit, Takeda. co-founder of HilleVax and Venture Partner with Frazier.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

The Pharma Data

JUNE 1, 2022

has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Annaliesa is a world-class scientist with a track record of delivering both vaccines and therapeutics in pioneering new areas of science and where there is urgent unmet need.

Vaccination 40

Vaccination Vaccine Development Research 40

ACRP blog

MAY 16, 2023

For more than a century, Lind’s innovative research was overshadowed by the achievements of other famous inventors of the era, such as Benjamin Franklin, fellow Scotsman James Watt, and vaccine pioneer Edward Jenner. None of this work can be done without you, and science can only advance through collaboration.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Pharma Marketing Network

MARCH 2, 2022

According to Murray Aitken, IQVIA’s Senior VP and Executive Director of the IQVIA Institute for Human Data Science, “the pandemic has accelerated biopharmaceutical innovation.” 3 therapeutic areas with the most growth are oncology, gastrointestinal disorders, and neurology. IQVIA’s Report Highlights.

Drugs 52

Drugs Life Science Production Gene Therapy 52

VirTrial

OCTOBER 25, 2023

Vaccine studies can be large, multinational endeavors with sensitive timeframes, extended participation follow-up periods, multiphase designs, and critical data management needs. In recent years, Signant has been a part of more than 95 vaccine studies involving 140,000+ patients in more than 30 countries.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.

Life Science 113

Life Science Sales Scientist Vaccination 113

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. A focus on the representation of diverse patient populations in clinical trials will be a very good thing for the industry, but could be challenging.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

Pharma Marketing Network

MARCH 2, 2022

According to Murray Aitken, IQVIA’s Senior VP and Executive Director of the IQVIA Institute for Human Data Science, “the pandemic has accelerated biopharmaceutical innovation.” 3 therapeutic areas with the most growth are oncology, gastrointestinal disorders, and neurology. IQVIA’s Report Highlights.

Drugs 52

Drugs Life Science Production Gene Therapy 52

Drug Discovery World

JANUARY 21, 2024

Advances in this area are having a positive effect on both the commercial success of drug discovery and development organisations, as well as benefitting the health and wellbeing of the global population. His recent research focuses on vaccines against influenza and other (re)emerging viruses.

Protein 52

Protein Vaccination Vaccine Development 52

Drug Discovery World

APRIL 10, 2023

Diana Spencer explores the evolution of the Hyderabad life sciences hub. India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines and vaccines. Hyderabad is recognised as the vaccine hub of India.

Genome 52

Genome Genomics Drugs Life Science 52

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My Blezat herself plays an important role when it comes to EY’s work in this area. “I But outcomes were still very much a central focus, both for Blezat and for Reuters Pharma. “A

Life Science 98

Life Science Marketing Medicine Production 98

The Pharma Data

MAY 5, 2022

Using donations, partnerships and collective action, Foundation S will focus on three critical areas: childhood cancer, the health of communities most vulnerable to the effects of climate change and pollution, and access to lifesaving medicines and vaccines. ” Foundation S will operate as a “think & do tank.”

Vaccination 52

Vaccination Vaccine Medicine Development 52

pharmaphorum

MARCH 1, 2022

This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines).

Clinical Research 90

Clinical Research Research Vaccination Vaccine 90

Drug Discovery World

MARCH 13, 2024

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. UK-based molecular diagnostics group Yourgene operates in Singapore.

Life Science 69

Life Science Genome Genomics Research 69

pharmaphorum

DECEMBER 16, 2020

There are some areas where demand has been much higher than normal, but there are also an awful lot of areas where treatment was stopped altogether and has since restarted. We’ve got so many great life science assets in the UK, but there are still some gaps – manufacturing capacity being one of them.”. “We

Vaccination 120

Vaccination Vaccine Life Science In-Vitro 120